Geno Consulting Services Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -44.49%
- Profit Growth -262.43%
- Ebitda -207.14%
- Net Worth -164.20%
- Total Assets -75.67%
About Geno Consulting Services
Geno Consulting Services Private Limited (GCSPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 2018 (Six years and four months 4 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Durgadevi Subramanian, Sushmitha Padmanabhan, and Kanchipuram Udayakumar serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U72900TN2018PTC125274
-
Company No.
125274
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Oct 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Geno Consulting Services?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Durgadevi Subramanian
|
Director | 15-Oct-2018 | Current |
|
Sushmitha Padmanabhan
|
Director | 15-Oct-2018 | Current |
|
Kanchipuram Udayakumar
|
Additional Director | 07-Apr-2022 | Current |
Financial Performance of Geno Consulting Services.
Geno Consulting Services Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 44.49% decrease. The company also saw a substantial fall in profitability, with a 262.43% decrease in profit. The company's net worth observed a substantial decline by a decrease of 164.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Geno Consulting Services?
In 2022, Geno Consulting Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Geno Consulting Services?
Unlock and access historical data on people associated with Geno Consulting Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Geno Consulting Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geno Consulting Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.